Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal
Clinical trial NCT01843452 · TERMINATED
Trial details
- NCT number
- NCT01843452
- Sponsor
- Centre Hospitalier Universitaire Vaudois
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2016-05-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.